Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
To be added to the distribution list, please email: DDeCastro@southlakeregional.org
In this episode, Dr. Heinz-Josef Lenz will discuss how to incorporate DPYD testing into daily practice of treating patients with 5-fu based therapy.
Key Opinion Leader:
Heinz-Josef Lenz MD. FACP Professor of Medicine J. Terrence Lanni Chair in Gastrointestinal Cancer Research Co-Director, USC Center for Molecular Pathway and Drug Discovery Co-Director of the USC Norris Center for Cancer Drug Development Medicine Keck School of Medicine, USC
Host: Shaqil Kassam MD. MSc. FRCPC skassam@southlakeregional.org Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
Outline: 0:00 - Introduction 3:20– Dr. Heinz-Josef Lenz - Biography 2: 00 – Is adjuvant Nivo standard of care for high risk resected MIUC 3:00 - Discussion
Previous episodes: https://www.blogtalkradio.com/medoncnow